Market Cap

OSE Immunotherapeutics SA Market Capitalization:

€119.5 Million

EUR as of Jan. 1, 2026

US$140.4 Million

business OSE Immunotherapeutics SA Company Profile

OSE Immunotherapeutics SA Main Stock Listings

Market Capitalization History of OSE Immunotherapeutics SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of OSE Immunotherapeutics SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €119.5 M -19.86%
Jan. 1, 2025 €149.1 M 63.90%
Jan. 1, 2024 €91.0 M -28.16%
Jan. 1, 2023 €126.6 M -18.73%
Jan. 1, 2022 €155.8 M -4.51%
Jan. 1, 2021 €163.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

OSE Immunotherapeutics SA Categories

France languages Healthcare languages Biotechnology
France Healthcare France Biotechnology

Stocks & Indices

OSE Immunotherapeutics SA has the following listings and related stock indices.


Stock: FSX: 6OP

Stock: Euronext: OSE

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.